126 related articles for article (PubMed ID: 13678862)
1. WTO takes a first step.
Lancet; 2003 Sep; 362(9386):753. PubMed ID: 13678862
[No Abstract] [Full Text] [Related]
2. TRIPS: whose interests are being served?
Kamal M; Bailey M
Lancet; 2003 Jul; 362(9380):260. PubMed ID: 12892952
[No Abstract] [Full Text] [Related]
3. WTO approves TRIPS amendment on importing under compulsory licensing.
Herget G
HIV AIDS Policy Law Rev; 2006 Apr; 11(1):23-4. PubMed ID: 16805011
[TBL] [Abstract][Full Text] [Related]
4. The primacy of public health considerations in defining poor quality medicines.
Newton PN; Amin AA; Bird C; Passmore P; Dukes G; Tomson G; Simons B; Bate R; Guerin PJ; White NJ
PLoS Med; 2011 Dec; 8(12):e1001139. PubMed ID: 22162953
[TBL] [Abstract][Full Text] [Related]
5. The WTO dispute settlement understanding: an unlikely weapon in the fight against AIDS.
Curti AM
Am J Law Med; 2001; 27(4):469-85. PubMed ID: 11837145
[No Abstract] [Full Text] [Related]
6. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
Oliveira MA; Bermudez JA; Chaves GC; Velásquez G
Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916
[TBL] [Abstract][Full Text] [Related]
7. Public health implications of world trade negotiations.
Adlung R
Lancet; 2004 Jan; 363(9402):82-3. PubMed ID: 14724014
[No Abstract] [Full Text] [Related]
8. Generic drugs. U.S. makes concession on WTO drug agreement.
AIDS Policy Law; 2003 Jul; 18(13):1. PubMed ID: 12913964
[No Abstract] [Full Text] [Related]
9. [The WTO and asbestos: commerce above all].
Terracini B
Epidemiol Prev; 2000; 24(6):245-6. PubMed ID: 11219199
[No Abstract] [Full Text] [Related]
10. TRIPS post-2005 and access to new antiretroviral treatments in southern countries: issues and challenges.
Orsi F; D'Almeida C; Hasenclever L; Camara M; Tigre P; Coriat B
AIDS; 2007 Oct; 21(15):1997-2003. PubMed ID: 17885289
[No Abstract] [Full Text] [Related]
11. World Trade Organisation reaches agreement on generic medicines. New deal will make it easier for poorer countries to import cut-price generic drugs made under compulsory licensing.
Kapp C
Lancet; 2003 Sep; 362(9386):807. PubMed ID: 13678876
[No Abstract] [Full Text] [Related]
12. WTO deadlines: why developing countries must act now to protect access to medicines.
Dinh K
Sex Health; 2004; 1(2):63-4. PubMed ID: 16334985
[No Abstract] [Full Text] [Related]
13. World Trade Organization still threatens supply of affordable AIDS drugs.
Hagmann M
Bull World Health Organ; 2002; 80(9):762-3. PubMed ID: 12378300
[No Abstract] [Full Text] [Related]
14. Trade, drugs, and health-care services.
Messerlin PA
Lancet; 2005 Mar 26-Apr 1; 365(9465):1198-200. PubMed ID: 15794975
[No Abstract] [Full Text] [Related]
15. Flexibilities in WTO law to support tobacco control regulation.
Voon T
Am J Law Med; 2013; 39(2-3):199-217. PubMed ID: 23815028
[No Abstract] [Full Text] [Related]
16. U.S. blocks trade agreement on generic drug access in poor countries.
James JS
AIDS Treat News; 2002 Dec; (386):4-6. PubMed ID: 12569874
[TBL] [Abstract][Full Text] [Related]
17. No agreement reached in talks on access to cheap drugs.
Loff B
Lancet; 2002 Dec; 360(9349):1951. PubMed ID: 12493275
[No Abstract] [Full Text] [Related]
18. Sleep less in Seattle.
Lancet; 1999 Dec; 354(9194):1917. PubMed ID: 10622287
[No Abstract] [Full Text] [Related]
19. Health policy and the WTO.
Bloche MG; Jungman ER
J Law Med Ethics; 2003; 31(4):529-45. PubMed ID: 14968656
[No Abstract] [Full Text] [Related]
20. Health and intellectual property rights.
Correa CM
Bull World Health Organ; 2001; 79(5):381. PubMed ID: 11417031
[No Abstract] [Full Text] [Related]
[Next] [New Search]
